Last quarter (Q4 2023), Arbutus Biopharma's total revenue was $2.15M, a decrease of -65.65% from the same quarter last year. In Q4, Arbutus Biopharma's net income was $-19.31M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 16.20M	$ 18.14M	$ 39.02M	$ 10.99M	$ 6.91M	$ 6.01M
Cost of Revenue	-	-	-	-	$ 47.48M	$ 57.60M
Gross Profit	$ 18.14M	$ 18.14M	$ 39.02M	$ 10.99M	$ -40.57M	$ -51.59M
Operating Expense	$ 48.04M	$ 96.24M	$ 104.47M	$ -84.51M	$ 64.18M	$ 77.36M
Operating Income	$ -31.72M	$ -78.10M	$ -65.46M	$ -71.65M	$ -57.27M	$ -71.34M
Net Non Operating Interest Income Expense	$ 5.23M	$ 5.23M	$ 466.00K	$ -2.73M	$ -3.27M	$ 3.00K
Other Income Expense	$ 69.00K	$ 69.00K	$ 4.39M	$ 2.04M	$ -3.21M	$ -95.04M
Pretax Income	$ -72.85M	$ -72.85M	$ -67.17M	$ -76.41M	$ -63.74M	$ -166.38M
Tax Provision	-	-	$ 4.44M	$ -4.29M	$ 0.00	$ -12.66M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -23.35M	$ -72.85M	$ -69.46M	$ -88.55M	$ -75.87M	$ -164.87M
Basic EPS	$ -0.43	$ -0.44	$ -0.46	$ -0.83	$ -1.00	$ -2.89
Diluted EPS	$ -0.43	$ -0.44	$ -0.46	$ -0.83	$ -1.00	$ -2.89
Basic Average Shares	$ 663.84M	$ 165.96M	$ 150.94M	$ 106.24M	$ 75.84M	$ 57.09M
Diluted Average Shares	$ 663.84M	$ 165.96M	$ 150.94M	$ 106.24M	$ 75.84M	$ 57.09M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 48.04M	$ 96.24M	$ -104.47M	$ -84.51M	$ 64.18M	$ 77.36M
Net Income From Continuing And Discontinued Operation	$ -72.85M	$ -72.85M	$ -69.46M	$ -76.41M	$ -63.74M	$ -153.72M
Normalized Income	$ -29.39M	-	-	-	$ -63.08M	$ -86.72M
Interest Expense	-	-	-	-	$ 4.01M	$ 2.11M
EBIT	$ -72.48M	$ -72.39M	$ -65.44M	$ -73.55M	$ -59.73M	$ -164.27M
EBITDA	$ -73.01M	$ -73.19M	$ -64.09M	$ -70.75M	$ -57.76M	$ -162.24M

Currency in USD

Arbutus Biopharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing